SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 01/01/2022 | 3. Issuer Name and Ticker or Trading Symbol MICROSTRATEGY Inc [ MSTR ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Class A Common Stock | 111 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (Right to buy) | (1) | 11/22/2029 | Class A Common Stock | 5,625 | 151.6 | D | |
Employee Stock Option (Right to buy) | (2) | 07/31/2030 | Class A Common Stock | 9,375 | 123.92 | D | |
Employee Stock Option (Right to buy) | (3) | 02/23/2031 | Class A Common Stock | 7,500 | 691.23 | D | |
Restricted Stock Units | (4) | (4) | Class A Common Stock | 600 | 0.00 | D | |
Restricted Stock Units | (5) | (5) | Class A Common Stock | 40 | 0.00 | D |
Explanation of Responses: |
1. Of the remaining 5,625 shares subject to this option, 1,875 shares are scheduled to vest on November 22, 2022, 1,875 shares are scheduled to vest on November 22, 2023, and 1,875 shares are scheduled to vest on November 22, 2024. |
2. Of the remaining 9,375 shares subject to this option, 3,125 shares are scheduled to vest on July 31, 2022, 3,125 shares are scheduled to vest on July 31, 2023, and 3,125 shares are scheduled to vest on July 31, 2024. |
3. Of the 7,500 shares subject to this option, 1,875 shares are scheduled to vest on February 23, 2022, 1,875 shares are scheduled to vest on February 23, 2023, and 1,875 shares are scheduled to vest on February 23, 2024. |
4. The remaining 600 restricted stock units will vest in equal annual installments over a three-year period, with 200 restricted stock units vesting on November 13, 2022, 200 restricted stock units vesting on November 13, 2023, and 200 restricted stock units vesting on November 13, 2024. |
5. The restricted stock units will vest in equal annual installments over a four-year period, with the first 25% of the restricted stock units vesting on November 15, 2022 and an additional 25% vesting on each anniversary thereafter until fully vested. |
Remarks: |
/s/ Kevin Adkisson | 01/12/2022 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |